Navigation Links
ReproCELL Launches Alzheimer's Disease Model Based on iPS-derived Human Neuronal Cells
Date:6/7/2012

YOKOHAMA, Japan, June 7, 2012 /PRNewswire/ --

ReproCELL, Inc. (CEO: Chikafumi Yokoyama PhD) announces today that the company will start commercializing human iPS-derived neurons in which an Alzheimer's disease related gene has been incorporated.

ReproCELL's scientists have successfully incorporated a gene related to Alzheimer's disease using homologous recombinant genetic engineering technology into undifferentiated human iPS cells and then differentiated them into neurons. In these cells, it has been confirmed that amyloid beta 42 is accumulated at higher levels compared to normal neurons. This phenomena is similar to what is observed in neurons of Alzheimer's patients. Accordingly, ReproCELL's scientists believe the newly developed iPS cells can be useful for drug screening to identify new therapeutic molecules to treat Alzheimer's disease patients.

The company will start marketing the cells on June 13th, 2012.

Details of data of the cells will be announced at the 10th annual meeting of ISSCR (International Society for Stem Cell Research) at Yokohama, Japan (June 13th-16th, 2012).

ReproCELL is a world-leading pioneer in commercializing human pluripotent stem cells as an effective tool for drug discovery and development. The company has successfully launched iPS-derived cardiomyocytes for cardiac toxicity testing, followed by the launch of iPS-derived dopaminergic neurons and hepatocytes for efficacy and toxicity screening of drug candidates.

This is the fourth product of the company using iPS technology and the first cellular disease model incorporating a disease-related gene.

Contact: info_en@reprocell.com Tel: 81-(0)45-475-3887
KDX Shin-Yokohama 381 bldg. 8F, 3-8-11 Shin-Yokohama, Kohoku-ku,
Yokohama, Kanagawa 222-0033, Japan


'/>"/>
SOURCE ReproCELL, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cellular Dynamics Launches MyCell™ Services
2. Kansas City Region Launches Contract Research Initiative To Speed The Development Of Health Care Innovation Worldwide
3. The Medical Letter Launches More@MedLetter
4. The official blog of The Medical Letter
5. Actavis Launches Generic Equivalent of Adalat® CC 90mg (Nifedipine Extended-Release Tablets, USP)
6. Glooko Launches the Glooko™ IR Adapter to Give ACCU-CHEK® Blood Glucose Meter Customers Access to the Glooko Logbook Solution
7. Mylan Launches Generic Version of Lipitor®
8. Cardinal Health Specialty Solutions Launches PathWare™ Decision Support Transaction Solutions
9. Mylan Launches Generic Version of Bonviva® Film Coated Tablets in the UK and Italy
10. Mylan Launches Generic Version of Viramune® Tablets
11. Actavis Launches First Generic Equivalent of Requip® XL (Ropinirole Extended-Release Tablets)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... -- Vivify Health, the pioneer and market leader of remote ... significant patent for the advancement of healthcare delivery from ... health.  This landmark patent provides the company with broad ... position as the leader in remote care.  ... to apply consumer mobile devices, wireless biometrics, EMR integration ...
(Date:4/20/2017)... 20, 2017 Research and Markets ... Pipeline and Market Prospects: Addressing Production Complexities Through Risk ... offering. ... "Global Biosimilar Pipeline and Market Prospects: Overcoming Production Complexities ... in-depth assessment of the current trends in the global ...
(Date:4/20/2017)... 20, 2017 Research and Markets has announced ... Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex ... ... technologies will rise from USD 20 Billion in 2015 to around ... Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and ...
Breaking Medicine Technology:
(Date:4/21/2017)... ... 21, 2017 , ... Young Asset Protection, an insurance provider ... the greater Pittsburgh metropolitan region, is joining forces with the local chapter of ... children. , Variety the Children’s Charity is a national organization dedicated to empowering, ...
(Date:4/21/2017)... ... 2017 , ... The adage “Show, don’t tell” applies perfectly to Green Builder ... esteemed VISION House demonstration project series. Manifesting the concept of right-sized living, the Flex ... to live affordably and abundantly without unduly taxing the resources of our beautiful planet. ...
(Date:4/21/2017)... , ... April 21, 2017 , ... ... it’s been named Agency of Record (AOR) for Theravent, Inc. , the ... snoring. Theravent’s parent company, Foundation Consumer Healthcare, is now working to expand distribution ...
(Date:4/21/2017)... ... 2017 , ... Crossover Symmetry , an evidence based ... lifestyle company that provides Human Performance Training and education to tactical athletes. Together ... military officers and others in service through the development and conditioning of overall ...
(Date:4/21/2017)... ... ... Alive for Wellness is a group of clinical professionals and ... Alive team uses advanced behavioral sciences treatment modalities to accomplish their goals. ... struggle is based on 10 modalities of treatment that include: , ...
Breaking Medicine News(10 mins):